Stalleril en es it fr

Stalleril Brand names, Stalleril Analogs

Stalleril Brand Names Mixture

  • No information avaliable

Stalleril Chemical_Formula


Stalleril RX_link

Stalleril fda sheet

Stalleril msds (material safety sheet)

Stalleril MSDS

Stalleril Synthesis Reference

Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)

Stalleril Molecular Weight

370.577 g/mol

Stalleril Melting Point

73 oC

Stalleril H2O Solubility

0.0336 mg/L

Stalleril State


Stalleril LogP


Stalleril Dosage Forms

Suspension; Tablet

Stalleril Indication

For the treatment of schizophrenia and generalized anxiety disorder.

Stalleril Pharmacology

Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Stalleril Absorption


Stalleril side effects and Toxicity

LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock

Stalleril Patient Information

Stalleril Organisms Affected

Humans and other mammals